Organophosphate-induced intermediate syndrome: Aetiology and relationships with myopathy

Toxicological Reviews

Volumn 25, Issue 1, 2006, Pages 1-14

  Karalliedde, Lakshman ^a   Baker, David ^a   Marrs, Timothy C ^b,c  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b CITY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; ATROPINE; BOTULINUM TOXIN A; CALCIUM ION; CARBAMIC ACID; CHOLINERGIC RECEPTOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE; DECAMETHONIUM; DILTIAZEM; DIMETHOATE; EDROPHONIUM; EOSIN; GLYCOGEN PHOSPHORYLASE; HEMATOXYLIN; ISOFENPHOS; METHAMIDOPHOS; MUSCARINIC RECEPTOR; ORGANOPHOSPHATE; OXIME; PARATHION; PESTICIDE; PRALIDOXIME; PRALIDOXIME MESILATE; PROTEINASE; PYRIDOSTIGMINE; SUXAMETHONIUM; TUBOCURARINE CHLORIDE;

CONTROLLED STUDY; CRANIAL NERVE; DECUBITUS; DEPOLARIZATION; DIARRHEA; DRUG POTENTIATION; ELECTROMYOGRAPHY; ELECTROPHYSIOLOGY; FASCICULATION; HUMAN; HYDROLYSIS; INTOXICATION; LUNG ASPIRATION; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; MYOPATHY; NONHUMAN; PATIENT MONITORING; POLYNEUROPATHY; POSITIVE END EXPIRATORY PRESSURE; RAT; REVIEW; UPREGULATION;

ANIMALS; CHOLINESTERASE REACTIVATORS; ELECTROMYOGRAPHY; HUMANS; MUSCLE WEAKNESS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; ORGANOPHOSPHORUS COMPOUNDS; OXIMES; PESTICIDES; RESPIRATION, ARTIFICIAL; RESPIRATORY INSUFFICIENCY; SYNDROME;

ANIMALIA;

EID: 33746413457     PISSN: 11762551     EISSN: 11762551     Source Type: Journal    
DOI: 10.2165/00139709-200625010-00001     Document Type: Review

References (61)

1. Lotti M, Moretto A, Capodicasa E, et al. Interactions between neuropathy target esterase and its inhibitors and the development of polyneuropathy. Toxicol Appl Pharmacol 1993; 122: 165-71
2. Lotti M, Moretto A. Organophosphate-induced delayed polyneuropathy. Toxicol Rev 2005; 24: 37-49
3. Johnson MK, Vale JA. Clinical management of acute organophosphate poisoning: an overview. In: Ballantyne B, Marrs TC, editors. Clinical and experimental toxicology of organophosphates and carbamates. Oxford: Butterworth-Heine-mann, 1992: 528-35
4. Senanayake N. Organophosphorus-induced delayed polyneuropathy. In: Karalliedde L, Feldman S, Henry J, et al., editors. Organophosphates and health. London: Imperial College Press, 2001: 159-73
5. Senanayake N, Karalliedde L. Neurotoxic effects of organophosphorus insecticides: an intermediate syndrome. N Engl J Med 1987; 316: 761-3
6. Nalin DR. Epidemic of suicide by malathion poisoning in Guyana: report of 264 cases. Trop Geogr Med 1973; 25: 8-14
7. Wadia RS, Sadagopan C, Amin RB, et al. Neurological manifestations of organophosphorous insecticide poisoning. J Neurol Neurosurg Psychiatry 1974; 37: 841-7
8. Wadia RS, Chitra S, Amin RB, et al. Electrophysiological studies in acute organophosphate poisoning. J Neurol Neurosurg Psychiatry 1987; 50: 1442-8
9. Leon-S FE, Pradilla G, Vesga E. Neurological effects of organophosphate pesticides. BMJ 1996; 313: 690-1
10. Singh G, Mahajan R, Whig J. The importance of electrodiagnostic studies in acute organophosphate poisoning. J Neurol Sci 1998; 157: 191-200
11. Shailesh KK, Pais P, Vengamma B, et al. Clinical and electrophysiological study of intermediate syndrome in patients with organophosphorous poisoning. J Assoc Physicians India 1994; 42: 451-3
12. Thompson JW, Stocks RM. Brief bilateral vocal cord paralysis after insecticide poisoning: a new variant of toxicity syndrome. Arch Otolaryngol Head Neck Surg 1997; 123: 93-6
13. Senanayake N, Jayatissa SK. Sensori-motor polyneuropathy due to metronidazole. Ceylon Med J 1984; 29: 153-6
14. Tripathi AK, Misra UK. Ophthalmoplegia in dimethoate poisoning. J Assoc Physicians India 1996; 44: 225
15. Hikita H, Miyata M, Ishikawa S. Experimental study of chronic organophosphate (OP) intoxications in the beagle dogs. Activities of cholinesterases and residue of OP [in Japanese]. Nippon Ganka Gakkai Zasshi 1973; 77: 1254-65
16. Eddleston M, Mohammed F, Davies OJ, et al. Respiratory failure in acute organophosphate pesticide self-poisoning. Q J Med. In press
17. Feldman S. Effects of organophosphates on the neuromuscular junction and muscle. In: Karalliedde L, Feldman S, Henry J, et al., editors. Organophosphates and health. London: Imperial College Press, 2001; 199-215
18. Engel AG. Myasthenia gravis and myasthenic disorders. New York: Oxford University Press, 1999
19. Gutmann L, Besser R. Organophosphate intoxication: pharmacologic, neurophysiologic, clinical, and therapeutic considerations. Semin Neurol 1990; 10: 46-51
20. Bowman WC, Prior C, Marshall IG. Presynaptic receptors in the neuromuscular junction. Ann N Y Acad Sci 1990; 604: 69-81
21. De Wilde V, Vogelaers D, Colardyn F, et al. Postsynaptic neuromuscular dysfunction in organophosphate induced intermediate syndrome. Klin Wochenschr 1991; 69: 177-83
22. De Bleecker J, Willems J, van den Neucker K, et al. Prolonged toxicity with intermediate syndrome after combined parathion and methyl parathion poisoning. J Toxicol Clin Toxicol 1992; 30: 333-45
23. De Bleecker J, van den Neucker K, Willems J. The intermediate syndrome in organophosphate poisoning: presentation of a case and review of the literature. J Toxicol Clin Toxicol 1992; 30: 321-9
24. De Bleecker J, Van Den Abeele K, de Reuck J. Electromyography in relation to end-plate acetylcholinesterase in rats poisoned by different organophosphates. Neurotoxicology 1994; 15: 331-40
25. De Bleecker J, Meire VI, Pappens S. Quinidine prevents paraoxon-induced necrotizing myopathy in rats. Neurotoxicology 1998; 19: 833-8
26. Singh G, Avasthi G, Khurana D, et al. Neurophysiological monitoring of pharmacological manipulation in acute organophosphate (OP) poisoning: the effects of pralidoxime, magnesium sulphate and pancuronium. Electroencephalogr Clin Neurophysiol 1998; 107: 140-8
27. Avasthi G, Singh G. Serial neuro-electrophysiological studies in acute organophosphate poisoning: correlation with clinical findings, serum cholinesterase levels and atropine dosages. J Assoc Physicians India 2000; 48: 794-9
28. Stalberg E, Trontelj JV. Single fiber electromyography: studies in healthy and diseased muscle. 2nd ed. New York: Raven Press, 1994
29. Baker DJ, Sedgwick EM. Single fibre electromyographic changes in man after organophosphate exposure. Hum Exp Toxicol 1996; 15: 369-75
30. Sedgwick EM, Senanayake N. Pathophysiology of the intermediate syndrome of organophosphorus poisoning. J Neurol Neurosurg Psychiatry 1997; 62: 201-2
31. Xiao C, Niu Y, He F. Stimulation single fiber electromyography in rats with myasthenia induced by organophosphorus insecticides and their mixtures poisoning [in Chinese]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi 2002; 20: 125-7
32. Yang D, Li T, He F. Electroneurophysiological studies in rats of acute dimethoate poisoning. Toxicol Lett 1999; 107: 249-54
33. Kelly SS, Ferry CB, Bamforth JP. The effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles. Br J Pharmacol 1990; 99: 721-6
34. Kelly SS, Ferry CB, Bamforth JP, et al. Protection against the effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles. Br J Pharmacol 1992; 107: 867-72
35. Kelly SS, Ferry CB. The origin of the effects of an anticholinesterase on the latencies of action potentials in mouse skeletal muscles. Br J Pharmacol 1994; 111: 747-52
36. Smith AP. Long-term effects of the anticholinesterases sarin and soman on latencies of muscle action potentials in mouse diaphragm muscle. J Pharm Pharmacol 1993; 45: 176-81
37. Martyn JAJ, White DA, Gronert GA, et al. Up-and-down regulation of skeletal muscle acetylcholine receptors: effects on neuromuscular blockers. Anesthesiology 1992; 76: 822-43
38. Elmqvist D, Hofmann WW, Kugelberg J, et al. An electrophysiological investigation of neuromuscular transmission in myasthenia gravis. J Physiol 1964; 174: 417-34
39. Engel E. The molecular biology of end plate diseases. In: Salpeter MM, editor. The vertebrate neuromuscular junction. New York: Alan R. Liss Inc., 1987: 361-424
40. Zaimis E. The neuromuscular junction: areas of uncertainty. In: Zaimis E, editor. Handbook of experimental pharmacology vol. XXXXII: the neuromuscular junction. Berlin: Springer-Verlag, 1976: 1-18
41. Marshall CG, Ogden DC, Colquhoun D. The actions of suxamethonium (succinyldicholine) as an agonist and channel blocker at the nicotinic receptor of frog muscle. J Physiol 1990; 428: 155-74
42. Preusser H-J. Die Ultrastruktur der motorischen Endplatte im Zwerchfell der Ratte und Veranderungen nach Inhibierung der Acetylcholinesterase. Z Zellforsch Mikrosk Anat 1967; 80: 436-57
43. Karalliedde L, Henry JA. Effects of organophosphates on skeletal muscle. Hum Exp Toxicol 1993; 12: 289-96
44. de Reuck J, Willems J. Acute parathion poisoning: myopathic changes in the diaphragm. J Neurol 1975; 208: 309-14
45. Wecker L, Mrak RE, Dettbarn WD. Evidence of necrosis in human intercostal muscle following inhalation of an organophosphate insecticide. Fundam Appl Toxicol 1986; 6: 172-4
46. John M, Oommen A, Zachariah A. Muscle injury in organophosphorous poisoning and its role in the development of intermediate syndrome. Neurotoxicology 2003; 24: 43-53
47. Ariens AT, Meeter E, Wolthuis OL, et al. Reversible necrosis at the end-plate region in striated muscles of the rat poisoned with cholinesterase inhibitors. Experientia 1969; 25: 57-9
48. Gupta RC, Patterson GT, Dettbarn W-D, editor. Acute tabun toxicity; biochemical and histochemical consequences in brain and skeletal muscles of rat. Toxicology 1987; 46: 329-41
49. Gupta RC, Patterson GT, Dettbarn WD. Biochemical and histochemical alterations following acute soman intoxication in the rat. Toxicol Appl Pharmacol 1987; 87: 393-402
50. Inns RH, Tuckwell NJ, Bright JE, et al. Histochemical demonstration of calcium accumulation in muscle fibres after experimental organophosphate poisoning. Hum Exp Toxicol 1990; 9: 245-50
51. Bright JE, Inns RH, Tuckwell NJ, et al. A histochemical study of changes observed in the mouse diaphragm after organophosphate poisoning. Hum Exp Toxicol 1991; 10: 9-14
52. Hughes JN, Knight R, Brown RF, et al. Effects of experimental sarin intoxication on the morphology of the mouse diaphragm: a light and electron microscopical study. Int J Exp Pathol 1991; 72: 195-209
53. Britt JO, Martin JL, Okerberg CV, et al. Histopathologic changes in the brain, heart, and skeletal muscle of rhesus macaques, ten days after exposure to soman (an organophosphorus nerve agent). Comp Med 2000; 50: 133-9
54. Salpeter MM, Kasprzak H, Feng H, et al. Endplates after esterase inactivation in vivo: correlation between esterase concentration, functional response and fine structure. J Neurocytol 1979; 8: 95-115
55. Leonard JP, Salpeter MM. Agonist-induced myopathy at the neuromuscular junction is mediated by calcium. J Cell Biol 1979; 82: 811-9
56. Sket D, Dettbarn W-D, Clinton ME, et al. Prevention of diisopropylphosphorofluoridate-induced myopathy by botulinum toxin type A blockage of quantal release of acetylcholine. Acta Neuropathol 1991; 82: 134-42
57. Meshul CK. Calcium channel blocker reverses anticholinesterase-induced myopathy. Brain Res 1989; 497: 142-8
58. Cavaliere MJ, Puga FR, Calore EE, et al. Protective effect of pralidoxime on muscle fiber necrosis induced by organophosphate compounds. J Toxicol Clin Toxicol 1998; 36: 295-300
59. Tóth L, Karcsú S, Poberai M, et al. A light and electron microscopic histochemical study on the mechanism of DFP-induced acute and subacute myopathy. Neuropathol Appl Neurobiol 1981; 7: 399-410
60. Tóth L, Karcsú S, Poberai M, et al. Histochemical evidence for the role of Ca2+ and neutral protease in the development of the subacute myopathy induced by organophosphorus compounds. Acta Histochem 1983; 72: 71-5
61. Vanneste Y, Lison D. Biochemical changes associated with muscle fibre necrosis after experimental organophosphate poisoning. Hum Exp Toxicol 1993; 12: 365-70